Switzerland · 
Who invested in HAYA Therapeutics?
HAYA Therapeutics's investors include Earlybird Venture Capital, Sofinnova Partners, Eli Lilly, Innosuisse and Alexandria Venture Investments, and 10 more on record.
2026
$1.6MGrant$65MSeries A?Venture
Switzerland · Venture startup
Who invested in HAYA Therapeutics
Funding summaryUpdated 26 Oct 2026
$67Mraised across 3 rounds since 2025, from 4 sources
$1.6MGrant$65MSeries A
- Latest round
- VentureSept 2025
- Biggest round
- $65MSeries A · May 2025
- Investors
- 15 (3 led)
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Grant, $1.6M Feb 2025
- Biggest round
- $65M Series A · May 2025
- Usual gap between rounds
- 4 months the median of 2
The rounds
- Sept 2025VentureAmount undisclosed2 new3 returning
Source recorded
- May 2025
- Feb 2025
Founders and team
From HAYA Therapeutics's own website: 2 founders, 10 on the team.
- Denis DryginSenior Vice President of Development
- Mihaela RobertsSenior Vice President, Finance
- Eric AdamChief Operating Officer (COO)
- Jordan ShinChief Medical Officer (CMO)
- Jérôme AndriesChief Financial Officer (CFO)
- Richard LawChief Business Officer (CBO)
- Barry TichoIndependent Director
- Brian ThomasChairman
- Douglas L. MannChairperson
- Social MediaBoard of Directors
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Alexandria Venture InvestmentsVC firm1round
Schroders CapitalHedge fund1round
BERNINA BioinvestVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about HAYA Therapeutics
How much has HAYA Therapeutics raised?
HAYA Therapeutics has raised $67M across 3 rounds since 2025. One round did not disclose an amount, so the total is a floor.
When did HAYA Therapeutics last raise?
HAYA Therapeutics's most recent round was a Venture in Sept 2025.
What was HAYA Therapeutics's biggest round?
HAYA Therapeutics's largest round on record is $65M (Series A), in May 2025, led by Earlybird Venture Capital.
Who backed HAYA Therapeutics first?
HAYA Therapeutics's first round on record, in Feb 2025, was backed by Innosuisse.
What stage is HAYA Therapeutics at?
HAYA Therapeutics's latest named round is a Venture, in Sept 2025.
Where is HAYA Therapeutics based?
HAYA Therapeutics is based in Switzerland.
Who led HAYA Therapeutics's rounds?
Innosuisse led the Grant in 2025; Earlybird Venture Capital led the Series A in 2025.
Companies like HAYA Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.